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Abstract
Deleterious environmental factors during pregnancy influence fetal development and increase the 
risk of  cardiovascular and kidney disease in adult offspring. Undernutrition, protein restriction, 
excess salt, corticosteroids, or placental insufficiency disturb kidney development, causing a lower 
number of  nephrons (referred to as nephron underdosing). This in turn leads to hypertension and 
accelerated loss of  kidney function in the adult life of  the offspring. The ‘nephron underdosing’ 
can be observed with or without intrauterine growth restriction. A lower number of  nephrons have 
been confirmed in humans with hypertension.
Introduction
Prevalence and causes of  low birth-weight
Defined by the traditional birth-weight cut-off  
(<2500g) approximately 15 percent of  children 
have a low birth-weight [1] but in underdeveloped 
countries the proportion may be even higher, 
although this is not well documented because 
of  under-reporting. Birth-weight can be low 
either in newborns at term (defined as small for 
gestation age – SGA; below the 10th percentile) 
or in newborns born prematurely. Being ‘small 
for gestational age’ is the result of  restricted 
intra-uterine growth, potentially caused by a 
number of  factors, including poor nutrition and 
cigarette smoking, which are the most common 
predisposing factors in developing countries [2]. 
Several epidemiological studies documented a 
clear association between lower birth-weight 
and pathology in adult life, including increased 
rates of  coronary heart disease, strokes, type 2 
diabetes mellitus, adiposity, metabolic syndrome 
and osteoporosis. [3-7]. Even in the absence of  
risk factors during the gestational period, events 
in the perinatal period may also cause adverse 
effects in adult life [8, 9]. When, in addition, risk 
factors are operational in adult life, the sequelae 
acquired in the perinatal period may definitely be 
amplified further [10].
Corresponding author: Nadezda Koleganova MD, Institute of  Pathology, University of  Heidelberg, Im Neuenheimer Feld 220/221, 
D-69120 Heidelberg, Germany.
Tel: +49-6221-5639917  Fax: +49-6221-565251
E-mail: nad_ko@gmx.de




Underlying mechanisms linking maternal 
constraint to fetal outcome
In the development of  mammals, environmental 
information (such as nutrient status) is relayed 
from the mother to the offspring through 
the placenta and through lactation. So called 
‘maternal constraint’ is responsible for the fact 
that for instance, growth of  the fetus corresponds 
to the size of  the mother’s body [11]. Maternal 
constraint may further comprise limitations, 
for example placental size and/or perfusion, 
impacting on nutrition of  the fetus. Modification 
of  gene expression, especially the expression of  
growth factors, may also play a role. [12]
The hypothesis proposed by Barker [13] provided 
a framework linking developmental deficits to 
pathology in adult life. The concept implies that 
adaptive responses of  the fetus to stimuli of  
maternal origin increase the long-term risk of  
disease in the offspring. Such fetal responses include 
changes in metabolism, hormone production or 
tissue sensitivity to hormones – all of  which may 
affect the development of  various organs, resulting 
in persistent alterations of  physiological and 
metabolic homeostatic set points. In this perspective 
reduced overall fetal body growth is seen not as a 
causal factor for the long-term consequences, but 
rather as a marker of  a coordinated fetal response 
to an adverse intrauterine environment. The long 
term consequences of  such adverse intrauterine 
environments may not be evident at birth, but 
as a consequence of  altered tissue and organ 
development may alter adaptive responses later in 
life [14].
Disruption of  fetal development depends on the 
nature, intensity, and timing of  the environmental 
challenges: 
- Toxins or extreme conditions may cause 
severe defects – teratogenesis. 
- A substantial, but not disruptive challenge, 
such as malnutrition during pregnancy, may 
induce an immediate defence response 
of  the developing organism, causing 
a phenotype called ‘thrifty’ [6], usually 
involving growth reduction. 
- Environmental influences which do not 
elicit immediate defence mechanisms may 
still result in phenotypic adaptation.
It has been hypothesised that such adaptations, 
termed ‘predictive adaptive responses’ [15], 
are an effort to adjust the physiology to the 
anticipated later environment. According to this 
interpretation, poor intrauterine nutrition leads 
to accumulation of  fat tissue, ‘because’ it will be 
beneficial if  the postnatal environment continues 
to offer scarce food supply. If  on the other hand 
the postnatal environment is nutrient rich, this 
‘protective’ mechanism would lead to adiposity 
and increased cardiovascular risk.
The effects of  developmental plasticity have 
been documented by numerous animal studies. 
Dietary, endocrinal, or physical challenges at 
various time points during pregnancy and weaning 
induce long-lasting changes in the physiology of  
the offspring. The most commonly used animal 
models involve  prenatal nutrient imbalance 
induced by a global undernutrition of  the mother 
[16] or by protein restriction using an isocaloric 
diet [17].
The nutrition of  the fetus depends on several 
factors:
- on the delivery of  oxygen via the uterine 
circulation,
- on the quality of  placentation including the 
placental transfer function, 
- and finally on the ability of  the fetus to 
deliver the nutrients from the placenta to 
peripheral tissues. 
For example dietary deprivation of  the mother 
rat in the pre-implantation period causes low 
birth-weight of  the offspring and hypertension 
in adult life [18].
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Another example is exposure of  the mother rat 
to glucocorticoid excess. The adult offspring of  
such mother rats present with hypertension [19], 
insulin resistance [20], altered gene expression in 
the brain  and increased sensitivity to stress [21]. 
Fetal programming of  kidney structure
Nephron underdosing and hypertension
Maternal dietary restriction causes lower nephron 
numbers in the kidneys of  the offspring (nephron 
underdosing).
Low birth-weight [22] as well as low placenta 
weight [23] predispose to hypertension, as 
originally proposed by Brenner [24]. In humans 
a correlation exists between blood pressure 
and birth-weight: the lower the birth-weight 
the higher the blood pressure in the adult [25] 
and it has been documented that subjects with 
hypertension have significantly fewer nephrons 
compared to age- and gender-matched controls 
[26].
Low birth-weight is also linked to increased 
cardiovascular risk which may in turn be 
mediated in part by reduced renal function – a 
known major cardiovascular risk factor [27]. A 
history of  low birth-weight is also associated 
with higher salt sensitivity of  blood pressure [28] 
and is paralleled by reduced vascular calibers, for 
example of  retinal arterioles [29].
The age at which low nephron number arises seems 
to be an important factor in the development of  
hypertension. Fehrman-Ekholm et al. [30] found 
that the prevalence of  hypertension in 402 living 
kidney donors was not different from the general 
population. A metanalysis by Boudville et al. [31] 
including 5,145 living kidney donors showed no 
more than an approximately 5 mmHg increase 
in blood pressure after kidney donation. This 
corresponds to observations in American soldiers 
uninephrectomised during the Second World War 
and studied 45 years later [32]. In contrast if  one 
kidney is missing at birth the risk of  hypertension 
approaches 50 percent by the age of  40 years 
and this is accompanied by a high risk of  kidney 
dysfunction [33]. These findings in humans are 
similar to what is seen in animal models: neonatal 
uninephrectomy causes salt-sensitive high blood 
pressure and glomerulosclerosis [34] while 
scarcely any blood pressure change is seen after 
uninephrectomy at a later age.
Development of  hypertension in subjects with 
lower nephron number depends on a number 
of  as yet unspecified factors. In rat models the 
severity of  hypertension in the offspring depends 
on gender, with males having more severe blood 
pressure increase [35]. Genetic background 
modifies the increase of  blood pressure in 
humans. Low nephron number correlates well 
with hypertension in Whites but not in Blacks 
[36, 37].
In the rat the renin-angiotensin system expressed 
in the kidney during development seems to play 
a crucial role in regulating the nephron number 
and being altered by maternal undernutrition [38, 
39].
Nephron underdosing and kidney 
malfunction
Low birth-weight with presumed nephron deficit 
does not only increase the risk of  hypertension 
later in life [17, 40], but is also associated with 
lower glomerular filtration rate (GFR) at a 
young age [41], specifically with a more rapid 
progression of  primary kidney disease [42, 43] 
and a higher risk of  preterminal or terminal 
renal failure [44-46]. Progression of  any chronic 
kidney disease may be further facilitated by 
comorbidities which are more prevalent in 
individuals with low birth-weight: hypertension, 
insulin resistance, dysglycaemia, and diabetes. 
Extremely low birth-weight may even cause a 
unique form of  nephrotic syndrome, in other 
words, focal segmental glomerulosclerosis [47]. 
Individuals born with one kidney have at a young 
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age a higher risk of  proteinuria, hypertension and 
reduced renal function [33]. 
Manalich documented that neonates with low 
birth-weight have fewer but bigger glomeruli 
[48] as found in animal experiments where this is 
associated with renal malfunction [41] including 
renal failure [49]. Recent studies demonstrated 
that birth-weight correlates directly with kidney 
size in infants and children as well as with 
nephron numbers at all ages [36, 50-52].
It is thought that low numbers of  glomeruli at 
birth lead to compensatory hypertrophy in order 
to maintain the filtration rate with consecutive 
single nephron hyperfiltration, intraglomerular 
hypertension, premature sclerosis of  the 
glomeruli and finally accelerated loss of  kidney 
function [53, 54]. In humans nephrogenesis is 
completed by the 36th week of  pregnancy [55]. 
Nonetheless Rodriquez [55] demonstrated that 
in premature (<35 wk) newborns nephrogenesis 
may continue even postnatally for up to 40 days 
after birth, but the final nephron number still 
remains subnormal. Some of  the interventions 
used in premature newborns (for example, non-
steroidal anti-inflammatory drugs, gentamycin) 
are known nephrotoxins and have been shown 
to diminish nephron number in rodents [56]. 
Children born small for their age (SGA) [57] are 
not only born with small kidneys, but their kidney 
growth is subsequently reduced until 18 months 
of  age.
In a study of  422 young people (46.7 percent 
men) Keijzer-Veen et al. found that participants 
with intrauterine growth-restriction at birth or 
premature birth had subtle kidney damage more 
often as reflected by the presence of  albuminuria 
and lower GFR at the age of  19 ± 0.2 years 
[58]. Hoy et al. [59] calculated that in Australian 
Aborigines low birth-weight is responsible for 
27 percent (95 percent CI, three to 45) of  the 
population-based prevalence of  albuminuria in 
young adults. Furthermore, in this population, low 
birth-weight correlated with small kidney size and 
subjects with smaller kidneys have had elevated 
blood pressure and albuminuria more often [52].
In experimental studies a relatively constant 
observation is the development of  kidneys 
with lower nephron numbers in offspring of  
mothers exposed in pregnancy to low protein 
intake [38], uterine underperfusion [60], maternal 
hyperglycaemia [61], maternal hyperinsulinaemia 
[62], inhibition of  the renin-angiotensin system 
[38], high and low maternal salt intake [63] or 
corticosteroids [64]. 
In offspring of  dams fed a protein deficient 
diet, the standard procedure to study renal 
maldevelopment, elevated blood pressure and 
reduced nephron number were observed; this 
was accompanied by increased response to salt 
loading [38] and impaired vasodilatation of  the 
systemic arteries [65]. Epigenetic mechanisms 
are thought to be highly relevant for tissue-
specific gene expression and fetal programming. 
The epigenetic modifications include changes in 
methylation of  cytidine-guannosine nucleotides in 
promoter regions, changes in histone acetylation 
modifying chromatin structure, and post-
translational interference by micro RNAs [66]. 
The epigenetic modifications of  DNA acquired 
during development remain unchanged in mitotic 
cell divisions throughout a lifetime. It has been 
shown, in the rat, that maternal dietary protein 
restriction causes changes in methylation of  the 
promoter for the hepatic glucocorticoid receptor 
and the peroxisome proliferator-activated 
receptor α (PPAR-α) with consecutive alteration 
of  target gene expression in the offspring 
influencing carbohydrate and lipid metabolism 
[67, 68] and presumably also renal development. 
There is increasing focus on the role played by 
epigenetic process in developmental plasticity. 
Epigenetic change may involve both imprinted 
and non-imprinted genes, and maternal 
nutrition has been demonstrated to influence 
the methylation of  both types. Epigenetic 
modifications have also been demonstrated in 
p53 in the kidney influencing renal apoptosis 
[69], in the angiotensin II type 1b receptor in 
the adrenal gland modifying blood pressure [70], 
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and in the hypothalamic glucocorticoid receptor 
influencing response to stress [71]. The epigenetic 
modification in response to stimuli in the mother 
is gene-specific. For example a low protein diet 
in the mother modifies the methylation of  the 
PPAR-α but not of  the closely related PPAR-γ in 
the offspring [67]. The phenotypic manifestations 
of  these epigenetic modifications may be obscure 
until later in life if  they affect genes responding to 
specific environmental challenges (for example, 
overnutrition, high-fat diet and so on). Moreover 
such epigenetic modifications can be transferred 
on to further generations (in other words, F2) 
without further insults to the F1 generation [72].
Another key player in kidney development is the 
renin-angiotensin system. A properly functioning 
renin-angiotensin system is crucial for kidney 
development. The expression of  angiotensinogen 
in the rat kidney increases during late gestation 
and reaches a maximum around birth where the 
expression is considerably higher than in the 
adult. Renin mRNA is detected in the kidney from 
embryonic day 17 and levels are approximately 
20-fold and 10-fold higher than in adults at 
embryonic day 20 and at birth, respectively [73]. 
The renal content of  angiotensin II is several-fold 
higher in newborns than in adults. Angiotensin II 
has been shown to modulate growth in several 
cell and tissue types [74, 75]. The expression 
of  angiotensin II receptors in neonatal kidneys 
is also higher than in adult life [76]. The type 1 
angiotensin II receptor (AT1) is found in the 
renal glomeruli of  newborn rats during cellular 
proliferation and differentiation. The expression 
of  type 2 angiotensin II receptor (AT2) is high 
during fetal development and decreases after 
birth, suggesting its role in cell differentiation 
[78]. These data explain that RAS blockade 
interferes with kidney development.
Other studies found reduced expression of  the 
antiapoptotic homeobox gene product paired 
box 2 (Pax-2) in kidneys with a reduced number 
of  nephrons [79, 80].
The role of  the environment in later life
Both clinical and experimental data document 
interaction between the environment in early 
development and the environment in later life 
[16, 81]. A telling example is children born 
small who later develop obesity and a greater 
risk of  lifestyle disease [82]. In an experiment 
by Vickers et al. [16] rats born to mothers that 
were undernourished during pregnancy were 
characterised by hyperphagia, accelerated weight 
gain, hyperinsulinaemia, hyperleptinaemia and 
hypertension compared with those born to 
normal mothers. With respect to kidney disease 
this implies that apart from the amplification of  
renal risk by hypertension, the increased risk of  
kidney dysfunction imposed by low birth-weight 
is further potentiated by obesity in adult life in 
this age of  a worldwide obesity epidemic [83].
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